Clinical Trials Browser

Unknown × Interventional × Laryngeal Diseases × Clear all

NCT03737968 2023-03-21

Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.

Phase 2 Unknown

Laryngeal Diseases

NCT05679856 2023-01-11

VC-Larynx

Phase NA Unknown

Laryngeal Diseases, Laryngeal Neoplasms

NCT00396617 2012-07-02

Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy

Phase 1 Unknown

Carcinoma, Laryngeal Diseases, Laryngeal Neoplasms, Pharyngeal Neoplasms